1. Home
  2. SFM vs TVTX Comparison

SFM vs TVTX Comparison

Compare SFM & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sprouts Farmers Market Inc.

SFM

Sprouts Farmers Market Inc.

N/A

Current Price

$52.04

Market Cap

4.5B

ML Signal

N/A

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

N/A

Current Price

$50.82

Market Cap

4.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SFM
TVTX
Founded
2002
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.7B
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
SFM
TVTX
Price
$52.04
$50.82
Analyst Decision
Hold
Strong Buy
Analyst Count
16
15
Target Price
$56.92
★ $73.43
AVG Volume (30 Days)
★ 4.2M
2.1M
Earning Date
10-28-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
41.60
★ 92.89
EPS
★ 4.30
N/A
Revenue
★ $8,806,159,000.00
N/A
Revenue This Year
$5.96
$55.96
Revenue Next Year
$4.84
$48.63
P/E Ratio
$11.96
★ N/A
Revenue Growth
★ 14.08
N/A
52 Week Low
$47.35
$22.59
52 Week High
$94.89
$68.73

Technical Indicators

Market Signals
Indicator
SFM
TVTX
Relative Strength Index (RSI) 39.57 44.19
Support Level $47.35 $49.46
Resistance Level $87.91 $54.43
Average True Range (ATR) 2.89 2.61
MACD -0.06 0.49
Stochastic Oscillator 23.75 70.30

Price Performance

Historical Comparison
SFM
TVTX

About SFM Sprouts Farmers Market Inc.

Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: